On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema
Allergy
.
2018 Aug;73(8):1751-1753.
doi: 10.1111/all.13324.
Authors
A E Germenis
1
2
,
G Loules
2
,
M Zamanakou
2
,
F Psarros
3
,
T González-Quevedo
4
,
M Speletas
1
,
K Bork
5
,
K Wulff
6
,
L Steinmüller-Magin
7
,
I Braenne
8
,
P Staubach-Renz
5
,
G Witzke
5
,
J Hardt
9
Affiliations
1
Department of Immunology, School of Medicine, University of Thessaly, Larissa, Greece.
2
CeMIA S.A., Larissa, Greece.
3
Department of Allergology, Navy Hospital, Athens, Greece.
4
Reference Unit for Angioedema in Andalusia, Allergy Department, Virgen del Rocío University Hospital, Seville, Spain.
5
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany.
6
University Medicine, Ernst Moritz Arndt University, Greifswald, Germany.
7
Institute of Laboratory Medicine and Human Genetics, Singen, Germany.
8
Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
9
Department of Medical Psychology and Medical Sociology, Johannes Gutenberg University, Mainz, Germany.
PMID:
30009523
DOI:
10.1111/all.13324
No abstract available
Publication types
Letter
Comment
MeSH terms
Angioedemas, Hereditary*
Complement C1 Inhibitor Protein / genetics
Humans
Mutation
Plasminogen
Virulence
Substances
Complement C1 Inhibitor Protein
Plasminogen